Contribution of Flexig mobile application to assess adherence of patients treated with immunoglobulins in chronic diseases

Contribution of Flexig mobile application to assess adherence of patients treated with immunoglobulins in chronic diseases

Background: Long-term therapeutic adherence remains an essential challenge for better management of chronic diseases. It is estimated at 50% in developed countries. Objective: The study aimed to evaluate, under real conditions, the influence of satisfaction with Flexig use on adherence to subcutaneo...

Full description

Bibliographic Details
Main Authors: Taylor Pindi Sala, MD, PhD, Daniel Matondo Masisa, MD, MPH, Jean Charles Crave, MD, PhD, Chafke Belmokhtar, PhD, Guillaume LeNy, PhamD, Hippolyte Situakibanza, MD, PhD, Martin Duracinsky, MD, PhD, Patrick Cherin, MD, PhD, Olivier Chassany, MD, PhD
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Journal of Allergy and Clinical Immunology: Global
Subjects:
Therapeutic adherence
Flexig
mHealth app
subcutaneous immunoglobulin
chronic dysimmunity diseases
home monitoring
Online Access:http://www.sciencedirect.com/science/article/pii/S277282932300098X

Internet

http://www.sciencedirect.com/science/article/pii/S277282932300098X

Similar Items